| abstract |
The present invention relates to a novel purinone compound, a pharmaceutically acceptable salt thereof, a method for preparing the compound, and a pharmaceutical use of the compound as an anticancer agent, a neurological disease, an inflammatory disease, a bone disease, or a therapeutic agent for pain, specifically Because the novel compounds according to the present invention have excellent activity against CSF-1R among kinases, they are useful as pharmaceuticals for treating and preventing cancer such as acute leukemia, inflammatory diseases, neurological diseases, and bone disintegration diseases. |